Respiri (ASX:RSH) YoY EBITDA Growth : 25.00% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Respiri YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Respiri's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 25.00%.

Respiri's EBITDA per Share for the six months ended in Dec. 2023 was A$-0.00.

Respiri YoY EBITDA Growth Historical Data

The historical data trend for Respiri's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiri YoY EBITDA Growth Chart

Respiri Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

YoY EBITDA Growth

Get a 7-Day Free Trial

-111.11

10.53

41.18

30.00

Respiri Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															54.55	16.67	20.00	40.00	25.00

Respiri YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Respiri's YoY EBITDA Growth for the fiscal year that ended in Jun. 2023 is calculated as:

	YoY EBITDA Growth (A: Jun. 2023 )
=	(EBITDA per Share (A: Jun. 2023 )	-	EBITDA per Share (A: Jun. 2022 ))	/	\| EBITDA per Share (A: Jun. 2022 ) \|
=	(-0.007	-	-0.01)	/	\| -0.01 \|
=	30.00 %

Respiri's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-0.003	-	-0.004)	/	\| -0.004 \|
=	25.00 %

Respiri YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Respiri's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Respiri (ASX:RSH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Respiri Ltd (ASX:RSH) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

RSHUF:USA

Address

432 St Kilda Road, Level 9, Melbourne, VIC, AUS, 3004

Website

https://respiri.co

Respiri Ltd is a company engaged in the research, development, and commercialization of medical devices and the production of mobile health applications for the management of asthma and related chronic respiratory diseases. It operates through the following segments: The Australia segment includes research, development, and commercialisation of medical devices, and the production of mobile health applications in Australia. The company generates revenue through Medical Devices Segment in Australia.

Respiri (ASX:RSH) Headlines

No Headlines